Home/ Stocks/ DMAA

Drugs Made In America Acquisition Corp. Ordinary Shares

DMAA XNAS

$10.60 +0.00 (+0.00%) ▲ 15-min delayed

Open

$10.57

High

$10.60

Low

$10.57

Volume

46.3K

Market Cap

$357.40M

About Drugs Made In America Acquisition Corp. Ordinary Shares

Drugs Made In America Acquisition Corp is a blank check company.

Sector: BLANK CHECKS

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	N/A	$5.94M	N/A
FY 2025	N/A	$5.94M	N/A
Q3 2025	N/A	$2.18M	N/A
Q2 2025	N/A	$2.29M	N/A

Earnings & Analyst Ratings

Next Earnings: Mon, Aug 3, 2026

Calendar →

Related Market News

No specific coverage for DMAA yet. Check out our latest market news or earnings calendar.

Get DMAA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Drugs Made In America Acquisition Corp. Ordinary Shares.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.